BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37990448)

  • 21. Comparison between High-Power Short-Duration and Conventional Ablation Strategy in Atrial Fibrillation: An Updated Meta-Analysis.
    Li M; Ma Y; Lin Q; Huang Y; Liu Y; Tu T; Liu Q
    Cardiovasc Ther; 2022; 2022():1065077. PubMed ID: 35975140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-power short-duration versus standard-power standard-duration settings for repeat atrial fibrillation ablation.
    Junarta J; Dikdan SJ; Upadhyay N; Bodempudi S; Shvili MY; Frisch DR
    Heart Vessels; 2022 Jun; 37(6):1003-1009. PubMed ID: 34846561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Randomized Trial of High vs Standard Power Radiofrequency Ablation for Pulmonary Vein Isolation: SHORT-AF.
    Lee AC; Voskoboinik A; Cheung CC; Yogi S; Tseng ZH; Moss JD; Dewland TA; Lee BK; Lee RJ; Hsia HH; Marcus GM; Vedantham V; Chieng D; Kistler PM; Dillon W; Vittinghoff E; Gerstenfeld EP
    JACC Clin Electrophysiol; 2023 Jul; 9(7 Pt 2):1038-1047. PubMed ID: 37495318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary vein isolation for atrial fibrillation using true high-power short-duration vs. cryoballoon ablation.
    Wörmann J; Lüker J; van den Bruck JH; Filipovic K; Erlhöfer S; Scheurlen C; Dittrich S; Schipper JH; Steven D; Sultan A
    Clin Res Cardiol; 2023 Jun; 112(6):846-852. PubMed ID: 37009942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced esophageal heating in high-power short-duration atrial fibrillation ablation in the contact force catheter era.
    Vassallo F; Meigre LL; Serpa E; Cunha CL; Carloni H; Simoes A; Amaral D; Lovatto C
    Pacing Clin Electrophysiol; 2021 Jul; 44(7):1185-1192. PubMed ID: 34081339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiofrequency ablation of atrial fibrillation-50 W or 90 W?
    Mueller J; Nentwich K; Ene E; Berkovitz A; Sonne K; Chakarov I; Barth S; Waechter C; Behnes M; Akin I; Halbfass P; Deneke T
    J Cardiovasc Electrophysiol; 2022 Dec; 33(12):2504-2513. PubMed ID: 36124396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes and impacts in early recurrences after atrial fibrillation ablation in contact force era: comparison of high-power short-duration with conventional technique-FIRST experience data.
    Vassallo F; Meigre LL; Serpa E; Cunha C; Simoes A; Carloni H; Amaral D; Meira K; Pezzin F
    J Interv Card Electrophysiol; 2021 Nov; 62(2):363-371. PubMed ID: 33151444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contact force and catheter stability are predictive metrics of successful pulmonary vein isolation with high-power short duration ablation in atrial fibrillation.
    Honarbakhsh S; Martin CA; Dhillon G; Gallagher M; Sohal M; Chow A; Ahsan S; Abbass H; Whittaker-Axon S; Lambiase PD; Davies MJ; Ginks M; Hunter RJ
    J Cardiovasc Electrophysiol; 2023 May; 34(5):1141-1151. PubMed ID: 36808788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Term Durability of High- and Very High-Power Short-Duration PVI by Invasive Remapping: The HPSD Remap Study.
    Szegedi N; Salló Z; Nagy VK; Osztheimer I; Hizoh I; Lakatos B; Boussoussou M; Orbán G; Boga M; Ferencz AB; Komlósi F; Tóth P; Perge P; Kovács A; Merkely B; Gellér L
    Circ Arrhythm Electrophysiol; 2024 Feb; 17(2):e012402. PubMed ID: 38284286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of high power shorter duration ablation for atrial fibrillation: A systematic review and meta-analysis.
    Li MF; Wu J; Jin CL; Chen CF; Xu YZ
    Int J Clin Pract; 2021 Apr; 75(4):e13732. PubMed ID: 32975347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and Efficacy of High Power Shorter Duration Ablation Guided by Ablation Index or Lesion Size Index in Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis.
    Liu X; Gui C; Wen W; He Y; Dai W; Zhong G
    J Interv Cardiol; 2021; 2021():5591590. PubMed ID: 34149322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of high-power short duration atrial fibrillation ablation in elderly patients.
    Müller J; Nentwich K; Berkovitz A; Ene E; Sonne K; Chakarov I; Barth S; Waechter C; Lüsebrink U; Behnes M; Akin I; Deneke T
    J Cardiovasc Electrophysiol; 2022 Jul; 33(7):1425-1434. PubMed ID: 35441414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esophageal safety in CLOSE-guided 50 W high-power-short-duration pulmonary vein isolation: The PREHEAT-PVI-registry.
    Francke A; Naumann G; Weidauer MC; Scharfe F; Schoen S; Wunderlich C; Christoph M
    J Cardiovasc Electrophysiol; 2022 Nov; 33(11):2276-2284. PubMed ID: 35979645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-Power Radiofrequency Catheter Ablation of Atrial Fibrillation: Using Late Gadolinium Enhancement Magnetic Resonance Imaging as a Novel Index of Esophageal Injury.
    Baher A; Kheirkhahan M; Rechenmacher SJ; Marashly Q; Kholmovski EG; Siebermair J; Acharya M; Aljuaid M; Morris AK; Kaur G; Han FT; Wilson BD; Steinberg BA; Marrouche NF; Chelu MG
    JACC Clin Electrophysiol; 2018 Dec; 4(12):1583-1594. PubMed ID: 30573123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reconnection patterns after CLOSE-guided 50 W high-power-short-duration circumferential pulmonary vein isolation and substrate modification-PV reconnection might no longer be an issue.
    Francke A; Scharfe F; Schoen S; Wunderlich C; Christoph M
    J Cardiovasc Electrophysiol; 2022 Jun; 33(6):1136-1145. PubMed ID: 35118734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of high-power short-duration atrial fibrillation ablation technique on the incidence of silent cerebral embolism: a prospective randomized controlled study.
    Chen WJ; Gan CX; Cai YW; Liu YY; Xiao PL; Zou LL; Xiong QS; Qin F; Tao XX; Li R; Du HA; Liu ZZ; Yin YH; Ling ZY
    BMC Med; 2023 Nov; 21(1):461. PubMed ID: 37996906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of lesion characteristics between conventional and high-power short-duration ablation using contact force-sensing catheter in patients with paroxysmal atrial fibrillation.
    Chen CC; Lee PT; Van Ba V; Chuang CM; Lin YJ; Lo LW; Hu YF; Chung FP; Lin CY; Chang TY; Vicera JJ; Huang TC; Liu CM; Wu CI; Lugtu IC; Jain A; Chang SL; Chen SA
    BMC Cardiovasc Disord; 2021 Aug; 21(1):387. PubMed ID: 34372779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 50-W vs 40-W During High-Power Short-Duration Ablation for Paroxysmal Atrial Fibrillation: A Multicenter Prospective Study.
    Costea A; Diaz JC; Osorio J; Matos CD; Hoyos C; Goyal S; Te C; D'Souza B; Rastogi M; Lopez-Cabanillas N; Ibanez LC; Thorne C; Varley AL; Zei PC; Sauer WH; Romero JE
    JACC Clin Electrophysiol; 2023 Dec; 9(12):2573-2583. PubMed ID: 37804258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safe and effective delivery of high-power, short-duration radiofrequency ablation lesions with a flexible-tip ablation catheter.
    Ptaszek LM; Koruth J; Santangeli P; Piccini JP; Ranjan R; Mahapatra S; Pipenhagen C; Fish JM; Moon LB; Ambrosius NM; Boudlali H; Jensen JA
    Heart Rhythm O2; 2023 Jan; 4(1):42-50. PubMed ID: 36713045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute oesophageal safety of high-power short duration with 50 W for atrial fibrillation ablation.
    Müller J; Berkovitz A; Halbfass P; Nentwich K; Ene E; Sonne K; Simu G; Chakarov I; Barth S; Waechter C; Behnes M; Akin I; Deneke T
    Europace; 2022 Jul; 24(6):928-937. PubMed ID: 35134155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.